Esperanza Del Pozo

Esperanza Del Pozo

Auto-generated profile, based on publicly available information

Esperanza Del Pozo

University of Granada

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2008 in Current Neuropharmacology
Verified
Journal Article
Open access
PDF file
EMEnrique Cobos Del Moral
Enrique Cobos Del Moral
JEJ. M. Entrena
J. M. Entrena
FNFrancisco R. Nieto
Francisco R. Nieto
CCC. M. Cendan
C. M. Cendan
EPE. Pozo
E. Pozo
Sigma () receptors, initially described as a subtype of opioid receptors, are now considered unique receptors. Pharmacological studies have distinguished two types of receptors, termed 1 and 2. Of these two subtypes, the 1 receptor has been cloned in humans and rodents, and its amino acid sequence shows no homology with other mammalian proteins. Several psychoactive drugs show high to moderate affinity for 1 receptors, including the antipsychotic haloperidol, the antidepressant drugs fluvoxamine and sertraline, and the psychostimulants cocaine and methamphetamine; in addition, the anticonvulsant drug phenytoin allosterically modulates 1 receptors. Certain neurosteroids are known to interact with 1 receptors, and have been proposed to be their endogenous ligands. These receptors are located in the plasma membrane and in subcellular membranes, particularly in the endoplasmic reticulum, where they play a modulatory role in intracellular Ca2+ signaling. Sigma1 receptors also play a modulatory role in the activity of some ion channels and in several neurotransmitter systems, mainly in glutamatergic neurotransmission. In accordance with their widespread modulatory role, 1 receptor ligands have been proposed to be useful in several therapeutic fields such as amnesic and cognitive deficits, depression and anxiety, schizophrenia, analgesia, and against some effects of drugs of abuse (such as cocaine and methamphetamine). In this review we provide an overview of the present knowledge of 1 receptors, focussing on 1 ligand neuropharmacology and the role of 1 receptors in behavioral animal studies, which have contributed greatly to the potential therapeutic applications of 1 ligands.


27 March 2009 in Psychopharmacology
Verified
Journal Article
Open access
PDF file
JEJosé M. Entrena
José M. Entrena
EMEnrique Cobos Del Moral
Enrique Cobos Del Moral
FNFrancisco R. Nieto
Francisco R. Nieto
CCCruz M. Cendán
Cruz M. Cendán
JBJosé M. Baeyens
José M. Baeyens
EPEsperanza Del Pozo
Esperanza Del Pozo
We evaluated the effects of haloperidol and its metabolites on capsaicin-induced mechanical hypersensitivity (allodynia) and on nociceptive pain induced by punctate mechanical stimuli in mice. Subcutaneous administration of haloperidol or its metabolites I or II (reduced haloperidol) dose-dependently reversed capsaicin-induced (1 μg, intraplantar) mechanical hypersensitivity of the hind paw (stimulated with a nonpainful, 0.5-g force, punctate stimulus). The order of potency of these drugs to induce antiallodynic effects was the order of their affinity for brain sigma-1 (σ1) receptor ([3H](+)-pentazocine-labeled). Antiallodynic activity of haloperidol and its metabolites was dose-dependently prevented by the selective σ1 receptor agonist PRE-084, but not by naloxone. These results suggest the involvement of σ1 receptors, but discard any role of the endogenous opioid system, on the antiallodynic effects. Dopamine receptor antagonism also appears unlikely to be involved in these effects, since the D2/D3 receptor antagonist (−)-sulpiride, which had no affinity for σ1 receptors, showed no antiallodynic effect. None of these drugs modified hind-paw withdrawal after a painful (4 g force) punctate mechanical stimulus in noncapsaicin-sensitized animals. As expected, the control drug gabapentin showed antiallodynic but not antinociceptive activity, whereas clonidine exhibited both activities and rofecoxib, used as negative control, showed neither. These results show that haloperidol and its metabolites I and II produce antiallodynic but not antinociceptive effects against punctate mechanical stimuli and suggest that their antiallodynic effect may be due to blockade of σ1 receptors but not to dopamine receptor antagonism.

17 June 2013 in European journal of pain
Verified
Journal Article
Closed access
PDF file
AHA. Hamdan
A. Hamdan
JCJuan De Dios Luna del Castillo
Juan De Dios Luna del Castillo
EPE. Del Pozo
E. Del Pozo
RGR. Gálvez
R. Gálvez

1 January 2005 in Synapse
Verified
Journal Article
Closed access
PDF file
ECEnrique J. Cobos
Enrique J. Cobos
GLGema Lucena
Gema Lucena
JBJosé M. Baeyens
José M. Baeyens
EPEsperanza Del Pozo
Esperanza Del Pozo

20 December 2014 in Social Psychiatry and Psychiatric Epidemiology
Verified
Journal Article
Closed access
PDF file
MGM. C. González-López
M. C. González-López
CRC. M. Rodríguez-López
C. M. Rodríguez-López
TPT. Parrón-Carreño
T. Parrón-Carreño
JCJuan De Dios Luna del Castillo
Juan De Dios Luna del Castillo
EPE. Del Pozo
E. Del Pozo